AzTrials
AzTrials

KeratoconusNCT04092426

Prevelance of Keratoconus

An observational study of Keratoconus, run by Assiut University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Keratoconus is a degenerative disease entity characterized by conical shape ectasia of the cornea. progressive conical deformation of the cornea leads to substantial astigmatism. Read more about this study

Who is it for?
Any age
Conditions the study is for
Keratoconus
What is being tested?
opthalmologic examination
How many people
300 participants
Where
No sites listed yet
Study dates
1 Oct 2019to 1 Oct 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Child, Adult, Older adult

Study population: patients with keratoconus in people attending refractive surgery

Who may be able to join

  • persons attending refractive surgery centers in Asssiut.
  • patients found to have keratoconus are included , based on history , clinical examination and corneal topography

Who cannot join

  • patients not attending those refractive surgery centers.
  • patients attending these centers but not diagnosed to be keratoconus .
  • Pregnancy or breastfeeding

About this study

Official title: Prevelance of Keratoconus in Individuals Attending Refreactive Surgery Centers in Assiut

Keratoconus is a degenerative disease entity characterized by conical shape ectasia of the cornea. progressive conical deformation of the cornea leads to substantial astigmatism. Patients who are at an advanced stage of ectasia are often led to corneal transplant or other treatments, which essentially aim at correcting the refractive error and not in treating the ectasia. The top of the protruding cone that corneal configuration may be close to the visual axis or below and nasal of that. The disease manifests during adolescence, followed by slow progressive course, although it is possible to stabilize anytime. In 85% of cases both eyes are affected, but the severity of the attack can present significant asymmetry.

Read the detailed description

Often in keratoconus a positive family history is present. Prevelance of keratoconus varies greatly worldwide.The reported prevalence of keratoconus varies widely depending upon the geographic location, diagnostic criteria used, and the cohort of patients selected. Environmental factors may contribute to the wide variation in prevalence.

the Middle East have higher prevalence than locations with cooler climates and less sunshine

Conditions
Keratoconus
Being tested
opthalmologic examination
Medical subject headings
Keratoconus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • opthalmologic examinationOther

    opthalmologic examination : Refraction Best corrected visual acuity Intraocular pressure Slit lamp examination

Study groups in NCT04092426
Study groupRoleWhat they receive
patients with keratoconuspatients with keratoconus attending refractive surgery centers in Assiut will be subjected to the following :- 1. Full history and clinical evaluation. 2. collection of individual data ( residency , occupation , special habbit , chronic illness ) 3. Analysis of results to assess prevelance of keratoconus and its distribution geographically in Assiut
Receives: Other: opthalmologic examination

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prevalence of keratoconus in different areas in assiut

    Number of keratoconus cases detected areas in indivduals attending refractive surgery centers in Assiut

    Measured: one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Sep 2019
  2. Study start1 Oct 2019 (estimated)
  3. Primary completion1 Oct 2020 (estimated)
  4. Study completion1 Oct 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04092426
Sponsor's protocol ID
keratoconus in assiut
Status last verified
Sep 2019
First submitted
15 Sep 2019
Last updated
17 Sep 2019
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Jonas JB, Nangia V, Matin A, Kulkarni M, Bhojwani K. Prevalence and associations of keratoconus in rural maharashtra in central India: the central India eye and medical study. Am J Ophthalmol. 2009 Nov;148(5):760-5. doi: 10.1016/j.ajo.2009.06.024. Epub 2009 Aug 11.

    PubMed 19674732

Questions about this trial

What is this clinical trial studying?

An observational study of Keratoconus, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Sep 2019. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prevalence of keratoconus in different areas in assiut (time frame: one year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04092426, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Sep 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in